• PDB80 Validation of the Updated Charlson Comorbidity Index (CCI) for Use in Patients with Diabetes or Asthma- A Comparison Study

    Nov 1, 2011, 00:00

  • PCN190 Use of Surrogate Measures of Survival in Economic Evaluations of Metastatic Breast Cancer Treatments

    Nov 1, 2011, 00:00

  • PMS47 The Long Term Cost-Effectiveness of Golimumab for the Treatment of Severe, Active Ankylosing Spondylitis in Adults Who Have Responded Inadequately to Conventional Therapy

    Nov 1, 2011, 00:00

  • PHP77 Exploring Different HRQOL Measures as Predictors of Future Health Care Expenditures

    Nov 1, 2011, 00:00

  • PIN62 A Multidisciplinary Support program in Hepatitis C Treatment- An Economic Evaluation

    Nov 1, 2011, 00:00

  • PDB1 Association Between Hypoglycemia and Medication Possession Ratio Among Veterans with Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2011, 00:00

  • PMH6 Effectiveness of Long-Acting Iinjectable Risperidone and Oral Atypical Antipsychotics in a 24-Months Observational Study in Adult Patients with Schizophrenia in Germany

    Nov 1, 2011, 00:00

  • PMS2 Risk and Cost of Infections in Rheumatoid Arthritis Patients Treated with anti-TNF therapy in Alberta, Canada

    Nov 1, 2011, 00:00

  • PDB61 Assessment of Quality of Life in Children and Adolescents with Type 1 Diabetes Mellitus

    Nov 1, 2011, 00:00

  • PSY7 Cost Of Managing Bleeding-Related Episodes (BRE) For Romiplostim Versus Standard Of Care (SOC) In Patients With Chronic Immune Thrombocytopenia (ITP) In Mexico

    Nov 1, 2011, 00:00

  • PCN181 The Health Related Quality of Life Data (HRQoL) for Health Technology Assessment (HTA) Process in Europe- Their Utilization and Impact on Opinions across HTA Agencies

    Nov 1, 2011, 00:00

  • PRM41 are General Population Data Suitable for Approximating Baseline Utility Values in Economic Models?

    Nov 1, 2011, 00:00

  • PCV37 Parametric Conditional Non-Frailty Model for Recurrent Events in Persons with Type 2 Diabetes in Sweden- The Example of Myocardial Infarction

    Nov 1, 2011, 00:00

  • PDB81 Assessment of Drug Adherence for Type 2 Diabetes Patients Using Vial or Pen Form Insulin- A Method to Adjust the Traditional Medication Possession Ratio

    Nov 1, 2011, 00:00

  • PND64 Cost-Minimization Analysis of IFNB-1B and Fingolimod among Multiple Sclerosis Patients in Germany

    Nov 1, 2011, 00:00

  • PCN50 First and Second Line Lung Cancer Treatment Utilization Patterns and associated Costs in A United States Health Care Claims Database

    Nov 1, 2011, 00:00

  • PHP120 The Past As Prologue- Use of Comparative Effectiveness Reviews (CER) in National Coverage Decision Making by Medicare in the United States and Predictions on Future Use of CER

    Nov 1, 2011, 00:00

  • VA3 A Cost-Effectiveness Analysis of A 10-Valent Pneumococcal Conjugate Vaccine in Children in Six Latin American Countries

    Nov 1, 2011, 00:00

  • PCV124 Reference Pricing, Originator Drugs and Consumerxs Choice

    Nov 1, 2011, 00:00

  • PMD69 Treatment of Urinary Tract infections is Common amongst Swedish Patients in Need of Chronic Catheterisation

    Nov 1, 2011, 00:00

  • PIN106 HIV Screening Programme in Community Pharmacies of the Basque Country

    Nov 1, 2011, 00:00

  • PIH36 the Quality of Life of Patients with the Top 5 Diseases and the Way to Reflect the Burden of Diseases in Thailand- A Country-Wide Multicenter EQ-5D Measurement, 2010

    Nov 1, 2011, 00:00

  • PND49 Initial Psychometric Properties of the Eurodolmed Questionnaire- A New Instrument to Measure Neuropathic Pain in Patients with Spinal Cord Injury (SCI) Based on Pain Intensity, Pain Interference and Pain Descriptors

    Nov 1, 2011, 00:00

  • PRS66 Drug Use Review in Patients with Bronchial Asthma - the Introduction of the Optimization Program of Therapy

    Nov 1, 2011, 00:00

  • PCV9 Optimal Treatment Shortfalls and Worse 12-Month Outcomes for Diabetic Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention in Contemporary Practi Data from the Multinational, Prospective, Antiplatelet Treatment Out ...

    Nov 1, 2011, 00:00

  • PMH55 An Examination of Antidepressant-Related Sexual Dysfunction and Degree of Enjoyment and Satisfaction with Daily Activities, and Current Medication in Employed Patients

    Nov 1, 2011, 00:00

  • PMH53 Follow-up of Health-Related Quality of Life in Young Heroin Users

    Nov 1, 2011, 00:00

  • PRM36 Comparing the Performance of the SF-6D and EQ-5D Across Diseases

    Nov 1, 2011, 00:00

  • PDB37 Injection of Long-Acting Somatostatin Analogs- A Cost Consequence Analysis for Three European Countries

    Nov 1, 2011, 00:00

  • PSY51 Epidemiology and Treatment Patterns of inhibitor Hemophilia in Russia- Patient-reported Data

    Nov 1, 2011, 00:00

  • PDB55 Translation and Validation Study of 14-Item Michigan Diabetes Knowledge Test (MDKT)- The Urdu Version

    Nov 1, 2011, 00:00

  • PDB25 Real-World Outcomes of Initiating Two Different Basal Insulin Therapies Via Disposable Pens Among Patients with Type 2 Diabetes in US Employer-Sponsored Health Plans

    Nov 1, 2011, 00:00

  • PRM58 Methodological Reviews of Economic Evaluations in Health Care- Are They Useful?

    Nov 1, 2011, 00:00

  • PHP4 The Appropriate Use of the Emergency Department for Paediatric Patients

    Nov 1, 2011, 00:00

  • PMH65 The Challenge of Adherence and Individualized Treatment in Severe Mental Disorders – A Nordic Perspective

    Nov 1, 2011, 00:00

  • PCV4 Comparative Efficacy of Maintenance of Sinus Rhythm Versus Rate Control Strategies in the Treatment of Atrial Fibrillation – Systematic Review and Meta-Analyses

    Nov 1, 2011, 00:00

  • PMH40 Economic Evaluation of Agomelatine for Major Depressive Disorder in Australia

    Nov 1, 2011, 00:00

  • PIN12 Analisis De Costo-Efectividad Del Uso De Proteina C Activada (PCA) En Enfermos Con Sepsis Grave Y Choque SÉptico En La Unidad De Cuidados Intensivos Del Hospital Regional 1° De Octubre Del ISSSTE

    Nov 1, 2011, 00:00

  • PCN58 The Cost of Strong Opioid Treatment of Oncological Pain in the Brazilian Private Health Care System

    Nov 1, 2011, 00:00

  • PIN11 The Impact of Directly Observed Therapy (DOT) in Patients with Tuberculosis

    Nov 1, 2011, 00:00

  • PCN43 Cost of HPV Associated Diseases in Saint-Petersburg

    Nov 1, 2011, 00:00

  • PSY50 Managing Pain Management- A Public Health Challenge

    Nov 1, 2011, 00:00

  • PND8 Prevalence and Procedure for Vertigo Follow-up in France

    Nov 1, 2011, 00:00

  • PDB15 Use of Hypoglicemic Drugs in Serbia- Pharmacotherapeutic Versus Pharmacoeconomic Aspects

    Nov 1, 2011, 00:00

  • PDB33 Cost of Diabetes Management to Cocoa Clinics in Ghana

    Nov 1, 2011, 00:00

  • PIH49 Otis- An Aid Tool for the Management of Itchy Scalps

    Nov 1, 2011, 00:00

  • PMS16 Potential Cost Saving of Epoetin Alfa Compared to Autologous Blood Donation or to No-Blood-Conservation-Strategy Before Elective Hip or Knee Surgery Due to reduction in Allogeneic Blood Transfusions and Its Side Effects

    Nov 1, 2011, 00:00

  • PMD63 Cost-Benefit analysis of CT Contrast Media (Iopromide) with Prefilled Cartridge Type Compared to Glass Bottle Type

    Nov 1, 2011, 00:00

  • PDB27 Projected Cost-Effectiveness of Exenatide Once Weekly Versus Exenatide Bid for the Treatment of Type 2 Diabetes in the UK

    Nov 1, 2011, 00:00

  • RM2 Aplicacion de Modelos De Regresion Con Stata Para El Estudio Del Consumo de Recursos En Unidades De Cuidados Intensivos Neonatales

    Nov 1, 2011, 00:00

  • PRM69 Measuring Relative Effectiveness in Europe- As in the USA, Here Too, It is Time to Turn the QALY Page

    Nov 1, 2011, 00:00

  • PSS31 Association Between Eq-5D and Dermatology Life Quality Index (Dlqi) in Patients With Chronic Hand Eczema

    Nov 1, 2011, 00:00

  • PMH13 Differences Between Patients Undergoing Augmentation or Switching of Antipsychotic Medications During Treatment of Schizophrenia

    Nov 1, 2011, 00:00

  • PND39 Hereditary Angioedema Health State Utility Valuation Study from the Perspective of A Representative Sample of the Australian General Public

    Nov 1, 2011, 00:00

  • PMD62 Validation of A Patient-Reported Outcome (PRO) Measure and A Clinician-Reported Outcome (CRO) Measure to assess Satisfaction and Preference with Pharmacological Stress Agents for Single Photon Emission Computed tomography (SPECT) Myoc ...

    Nov 1, 2011, 00:00

  • PMS52 Additional Medical Costs Due to Falls/Slips at Three Teaching Hospitals in Japan

    Nov 1, 2011, 00:00

  • PHP73 Government Reduces Public Pharmaceutical Expenditure in Hungary- Rational Decisions in Challenging Economic times?

    Nov 1, 2011, 00:00

  • PHP9 Temporary Use Authorizations- The Economic and Clinical Future of Drugs Used in the French Compassionate Program

    Nov 1, 2011, 00:00

  • PRS9 Disponibilidad A Pagar Por Un Metodo Efectivo Para Dejar De Fumar- Evidencias A Partir De La Encuesta Global De Tabaquismo En Adultos MÉxico 2009

    Nov 1, 2011, 00:00

  • PRS47 Optima Model-Based Cost-Utility Analysis of Fixed Combination Salmeterol/Fluticasone Versus Non-Fixed Combination Budesonide/Formoterol in One Pack for Bronchial Asthma Treatment

    Nov 1, 2011, 00:00

  • PCV109 Measuring Health Utility in Thai Stroke Patients

    Nov 1, 2011, 00:00

  • PCN184 Trends in Chemotherapy and Biologic Treatment of US Colorectal Cancer Patients

    Nov 1, 2011, 00:00

  • PIN10 Exchange Rate Or Power Purchase Parity For Economic Evaluation- Estimating The Costs Of Rotavirus Vaccination In A Six-Year Period Considering Data From Mexican Children

    Nov 1, 2011, 00:00

  • PUK13 Prevention in Predialitic Stage has Better Results in Health

    Nov 1, 2011, 00:00

  • CN3 Validation Study Of The Baseline Quality Of Life As A Prognostic Indicator Of SURVIVAL- A Pooled Analysis Of Individual Patient Data From NCIC Clinical Trials

    Nov 1, 2011, 00:00

  • PIN2 Facing Critical Health Events- Economic Impact Of AH1N1 Flu Epidemic In The Mexican Health Sector, 2009-2010

    Nov 1, 2011, 00:00

  • IN4 Morbidity and Mortality of Community Acquired Pneumonia in Adults in Six Countries in Latin America

    Nov 1, 2011, 00:00

  • PCV29 Recent In-Hospital Mortality Trends Among Patients with Heart Failure in the Netherlands

    Nov 1, 2011, 00:00

  • PND43 Validation of the Self Assessment of Treatment (SAT) Questionnaire

    Nov 1, 2011, 00:00

  • PMS2 Osteoporosis Medication Might Help reduce the incidence of Second Hip Fractures?

    Nov 1, 2011, 00:00

  • PDB74 Title- Implementation of Diabetes Programme Budget Marginal Analysis (PBMA) Exercise in an English Primary Care Trust (PCT)

    Nov 1, 2011, 00:00

  • PRS49 Economic Burden Attributable to Obesity in Adult Patients with Asthma in the United States

    Nov 1, 2011, 00:00

  • PCN20 Systematic Review of Skeletal Related Events in Breast Cancer

    Nov 1, 2011, 00:00

  • PHP128 In Depth Analysis of Health Technology Incorporation in Brazil. Is There A Cost-Effectiveness Measure of Threshold?

    Nov 1, 2011, 00:00

  • PRM54 Model and Covariate Visualization Aids for Enhancing the Interpretation of Steps in the High Dimensional Propensity Scoring Adjustment Procedure

    Nov 1, 2011, 00:00

  • PCN33 Cost Analysis- Treatment of Chemotherapy-Induced Anaemia with Erythropoiesis-Stimulating Agents (ESAs) in Spain

    Nov 1, 2011, 00:00

  • PND7 Disability Progression in Patients with Relapsing Remitting Multiple Sclerosis (RRMS) Who Experience Disease Activity Despite Previous Disease Modifying Therapy

    Nov 1, 2011, 00:00

  • PSS19 Glaucoma Management Cost as A Function of Disease Stage and Treatment Changes

    Nov 1, 2011, 00:00

  • PHP39 Toward a Better Drug Pricing Policy in Korea- Links Between Price Regulation and RD Activities

    Nov 1, 2011, 00:00

  • PHP54 Predictors of Avoidable Emergency Room Visits Among High Cost Medicaid Enrollees

    Nov 1, 2011, 00:00

  • PMH5 Analisis De Costo Efectividad Del Manejo Farmacologico De La Esquizofrenia Recurrente En Peru Ajustado Por La Adherencia Ai Tratamiento

    Nov 1, 2011, 00:00

  • PRM57 Revisiting HPV Vaccination- Why Existing CEAs Underestimate the Vaccine'S Cost-Effectiveness and Incorrectly Estimate Its Threshold Price

    Nov 1, 2011, 00:00

  • PND50 Public Preferences for the Predictive Genetic Test for Alzheimer'S Disease in the United States

    Nov 1, 2011, 00:00

  • PCV5 Thromboembolisms with Thrombopoietin Receptor Agonists- Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Nov 1, 2011, 00:00

  • PDB22 ‘Real-World' Clinical Outcomes of Exenatide Bid Compared to Insulin Glargine in Patients with Type 2 Diabetes

    Nov 1, 2011, 00:00

  • PRS45 Fully Incremental Cost-Effectiveness Analysis of Available Treatment Options in the Management of Severe COPD in the UK Setting

    Nov 1, 2011, 00:00

  • PRS38 The Cost-Effectiveness of Roflumilast for COPD in Sweden

    Nov 1, 2011, 00:00

  • PIH30 Endometriosis-Associated Pelvic Pain Treated with Dienogest or GNRH Analogues- Cost-Utility Comparison with 5 Years Time Horizon

    Nov 1, 2011, 00:00

  • PRM22 Microsimulation Methods Used for Health Policy Decisions in Personalized Medicine Under Constrained Resources

    Nov 1, 2011, 00:00

  • PSY49 Pain Management- Impact on Quality of Life

    Nov 1, 2011, 00:00

  • PSY36 Modelling the Cost-Effectiveness of Orlistat as a Treatment for Obesity in Primary Care

    Nov 1, 2011, 00:00

  • PCV38 Budget Impact of Changing Future Statin Use Patterns in Sweden

    Nov 1, 2011, 00:00

  • PCN104 Cost Minimization Analysis (CMA) of Capecitabine/Cisplatin (XP) vs. 5-Fu/Cisplatin (FP) Regimens in Advanced Gastric Cancer (AGC) Treatment in the Romanian Setting

    Nov 1, 2011, 00:00

  • PHP10 Two Phases Study on the Perspective of Health Care Professionals on Current Mechanisms for Authorizing the Prescription of Specifically Controlled Medicines in Spain

    Nov 1, 2011, 00:00

  • PDB58 How Much Do Patients with Type 2 Diabetes Value Improvements in Dosing Convenience? Results from a Conjoint Study

    Nov 1, 2011, 00:00

  • PSU4 Postoperative Prevalence Rate of Subependymal Giant Cell Astrocytoma (SEGA) Diagnosis and Repeated Sega Surgery in Patients with Tuberous Sclerosis Complex- A Real-World National Retrospective Cohort Study

    Nov 1, 2011, 00:00

  • PCV43 Budget Impact of the Implementation of a Treatment Protocol for Pulmonary Arterial Hypertension in A Referral Hospital

    Nov 1, 2011, 00:00

  • PRS53 Further Developments of the Asthma Life Impact Scale (ALIS)

    Nov 1, 2011, 00:00

  • PCN65 Cost-Effectiveness of Treating Metastatic Renal Cell Carcinoma (mRCC) Patients Whose Disease Failed on one Prior VEGF-TKI Therapy with Everolimus Compared to Treating with Best Supportive Care (BSC) Alone in Canada

    Nov 1, 2011, 00:00

  • AD4 Health Outcomes as a Function of Intentional and Unintentional Non-Adherence Among Eleven Costly Conditions in the EU

    Nov 1, 2011, 00:00

  • PGI5 Irritable Bowel Syndrome with Constipation (IBS-C)- A European-Focused Systematic Literature Review of Disease Burden

    Nov 1, 2011, 00:00

  • PCV7 Tobacco Addiction Influence in Later Development of Cardiovascular Events- 3 Years Follow-up

    Nov 1, 2011, 00:00

  • NI3 Economic Evaluation in Niche Markets- The Role of the UK's Advisory Group for National Specialised Services for Rare Diseases and Disorders

    Nov 1, 2011, 00:00

  • PRM13 Assessing the Methods for Systematic Reviews of Economic Evaluations

    Nov 1, 2011, 00:00

  • PRM63 Multiple Choices - How to Make Rational Decisions Across Several Interventions When Faced with Different Outcomes and Perspectives?

    Nov 1, 2011, 00:00

  • IN1 Evaluacion De COSTO-Efectividad Con El Uso De Linezolid Para El Tratamiento De Infecciones Complicadas De Piel Y Tejidos Blandos

    Nov 1, 2011, 00:00

  • PRS41 Cost-Effectiveness Analysis of Immunotherapy in Patients with Grass Pollen Allergic Rhinitis

    Nov 1, 2011, 00:00

  • TP3 Patrones De Tratamiento Y Costos De atencion En Pacientes Con Artritis Reumatoide, Desde La perspectiva Del Proveedor De Servicios De Salud En México

    Nov 1, 2011, 00:00

  • PDB12 Glargine Utilisation in Russia- A Prospective Study to Evaluate Patients Switched from NPH Insulin to Insulin Glargine Compared with Those Maintained on NPH

    Nov 1, 2011, 00:00

  • PHP103 Global Health Care Reforms and Pricing, Access and Health Outcomes Strategy

    Nov 1, 2011, 00:00

  • PHP41 Improving Use of Medicines in the Community Through Interventions

    Nov 1, 2011, 00:00

  • PCN117 Health Resource Utilisation (HRU) Associated with Skeletal-Related Events (SREs) in Patients with Bone Metastases (BMS)- Results From a Retrospective, Multinational European Study

    Nov 1, 2011, 00:00

  • PHP33 Knowledge, Attitude, and Practices (KAP) of Food Practitioners on Hazard Analysis and Critical Control Point (HACCP) in the Kumasi Metropolis, Ghana

    Nov 1, 2011, 00:00

  • PCN129 Mapping the Cancer-Specific EORTC QLQ-C30 and EORTC QLQ-BR23 to the Generic EQ-5D in Metastatic Breast Cancer Patients

    Nov 1, 2011, 00:00

  • PSY10 Budget Impact Analysis of Somatuline Autogel in the Management of Acromegaly in Spain

    Nov 1, 2011, 00:00

  • PMD11 Treatment of Overactive Bladder and Fecal incontinence Patients from the Canary islands with Sacral Neuromodulation- Is It worth to Have regional Centers of Excellence?

    Nov 1, 2011, 00:00

  • PHP47 Evaluation of General Public'S Expenditure on Health Products

    Nov 1, 2011, 00:00

  • PIN84 Lost in Translation- A Markov Model Cost Utility Analysis of Lopinavir/Ritonavir Vs Atazanavir + Ritonavir

    Nov 1, 2011, 00:00

  • PC3 Breast and Prostate Cancer Productivity Costs- A Comparison of the Human Capital Approach and Friction Cost Approach

    Nov 1, 2011, 00:00

  • PMD19 Cost-Effectiveness of Implantable Defibrillators after Myocardial Infarction Based on 8-Year Follow-up Data (MADIT II)

    Nov 1, 2011, 00:00

  • PMS33 Economic Evaluation of intravenously Ibandronate for the Treatment of Postmenopausal Osteoporosis in Mexico

    Nov 1, 2011, 00:00

  • PIH1 Impacto Presupuestal Del Uso De Levonorgestrel-Uis Frente A Otros Tratamientos En Menorragia Idiopatica En Colombia

    Nov 1, 2011, 00:00

  • PCV110 Health-Related Quality of Life After Venous Thromboembolism

    Nov 1, 2011, 00:00

  • PMH45 Comparison of the SF-6D and the EQ-5D in Patients with Schizophrenia

    Nov 1, 2011, 00:00

  • PHP127 Impact of Patient Access Schemes on NICE and SMC Guidance

    Nov 1, 2011, 00:00

  • PCV113 Patient Satisfaction with Stroke Prevention in Atrial Fibrillation – Medical-Driven Interim Results of a European Survey

    Nov 1, 2011, 00:00

  • PMH16 Budgetary Impact Analysis of Buprenorphine/Naloxone (Suboxone®) in Opioid Maintenance Treatment in Spain

    Nov 1, 2011, 00:00

  • PCN113 Cost-Utility Analysis of Combination Therapy of Pegylated Liposomal Doxorubicin(PLD) and Carboplatin for Korean Women with Platinum-Sensitive Ovarian Cancer

    Nov 1, 2011, 00:00

  • PRM9 What Guidance is Available for Budget Impact Analysis?

    Nov 1, 2011, 00:00

  • PCN93 Cost-Effectiveness of Treatment with New Agents in Advanced Non-Small-Cell Lung Cancer- A Systematic Review

    Nov 1, 2011, 00:00

  • PRS30 Identifying the Patient Population Where Treatment of Severe Allergic Asthma with Omalizumab (XOLAIR®) Exhibits Optimal Cost-Effectiveness in Australia

    Nov 1, 2011, 00:00

  • PRS50 The Dutch 1-Year Resource Use Results from the Experience Study, an International Registry of Real-World Outcomes for Asthma Patients Treated with Omalizumab

    Nov 1, 2011, 00:00

  • PHP86 Incorporating the Patient Perspective Into the Health Care Process- Experience from the C.A.T. Health System

    Nov 1, 2011, 00:00

  • PND37 An Examination of Resource Utilization Among Patients with Parkinson'S Disease Treated with Rasagiline or Selegiline

    Nov 1, 2011, 00:00

  • PCN188 Did Decision-Making Models from National Guidelines Change 1st Line Treatment Strategy for Patients with Metastatic Colorectal Cancer (MCRC)? The Results of Large Population Based Survey in Germany 2009

    Nov 1, 2011, 00:00

  • PDB16 First Results of the Post-Marketing Survey of Vildagliptin in France

    Nov 1, 2011, 00:00

  • PMH8 US Government Initiatives for Supporting Comparative Effectiveness Research, An Example from Project Libra

    Nov 1, 2011, 00:00

  • PUK2 Comparative Effectiveness of Investigational Compound Ferumoxytol for the Treatment of Iron Deficiency Anaemia in Chronic Kidney Disease- Systematic Review and Mixed Treatment Comparison

    Nov 1, 2011, 00:00

  • PIN110 Development of A Large Safety Database Using Studies Conducted During the Clinical Development and Post-Marketing of A Virosomal Aluminium-Free Hepatitis A Vaccine

    Nov 1, 2011, 00:00

  • PND68 Social Economic Burden and Health-Related Quality of Life in Patients with Rare Diseases in Europe (BURQOL-RD Project)- Methods of Selection of 10 Diseases for A European Survey

    Nov 1, 2011, 00:00

  • PHP23 Orphan Drug Access in Medicare Plans in the United States

    Nov 1, 2011, 00:00

  • PHP157 Using the CEAC for Value Based Pricing- Don'T Change the Goalposts

    Nov 1, 2011, 00:00

  • QA1 Measuring the Benefits of Health Care- Dalys and Qalys – Does the Choice of Measure Matter? A Case Study

    Nov 1, 2011, 00:00

  • PMH3 Cost-Effectiveness Of Paliperidone Palmitate For The Treatment Of Schizophrenia In MÉxico

    Nov 1, 2011, 00:00

  • PSS13 Economic Burden of Psoriasis and Diabetes in Patients With Psoriasis in the United States

    Nov 1, 2011, 00:00

  • PHP8 Measuring Adherence to Drug Treatment in Mexican Patients- A Systematic Review

    Nov 1, 2011, 00:00

  • PRM3 Dimensionality Of Comorbidities In Heath Related Quality Of Life Comorbidity INDEX

    Nov 1, 2011, 00:00

  • PRM27 Modelling the Brazilian Extended Consumer Price Index for Pharmaceutical Products- Comparison Between Exponential Smoothing and Box-Jenkins Methods

    Nov 1, 2011, 00:00

  • PMS1 Tumor Necrosis Factor Alpha Inhibitors for the Treatment of Active Ankylosing Spondylitis

    Nov 1, 2011, 00:00

  • PRM20 Comparison of Three Methods for Measuring Multi-Morbidity According to the Use of Health Resources in Primary Health Care

    Nov 1, 2011, 00:00

  • PIH45 Burden of Herpes Zoster and Post-Herpetic Neuralgia- Findings from a Cross-Sectional Patient Reported Outcomes Study

    Nov 1, 2011, 00:00

  • PRS24 Impact Of Age and Patient Co-Morbidities on Community Acquired Pneumonia (CAP) Related Costs at the Hospital Setting in a Well Defined Area Of Barcelona (Badalona, Spain)

    Nov 1, 2011, 00:00

  • PCN68 Cost-Effectiveness and Quality of Life Analysis of the Multicenter Itac02-01 Study- Prospective Randomized Comparison of Reduced Intensity Versus Non-Myeloablative Conditioning Regimen for Matched Related Allogeneic Stem Cell Transpla ...

    Nov 1, 2011, 00:00

  • PRM40 Improving the Measurement of quality of Life Based on Fuzzy Scale

    Nov 1, 2011, 00:00

  • PGI12 Gastroesophageal Reflux Disease Patients Who Switched from a Branded Proton Pump Inhibitor to a Generic One and Vice Versa- A Cost Comparison

    Nov 1, 2011, 00:00

  • PCN76 Cost-Effectiveness Analysis of Compliance with Clinical Practice Guidelines in Sarcoma Treatment- An Economic Evaluation in Two European Regions

    Nov 1, 2011, 00:00

  • PCN10 Comorbid Cardiovascular Diseases in Patients with Metastatic Colorectal Cancer

    Nov 1, 2011, 00:00

  • PIN48 Cost-Effectiveness of a Pentavalent Human-Bovine Reassortant Rotavirus Vaccine (RV5) in Japan

    Nov 1, 2011, 00:00

  • PCN75 Epidemiologic and Economic Impact of HPV (6/11/16/18) Vaccination in Turkey

    Nov 1, 2011, 00:00

  • PCV81 Cost-Effectiveness of Ticagrelor Versus Clopidogrel in Patients with Acute Coronary Syndrome- Results from the Plato Study- A Canadian Analysis

    Nov 1, 2011, 00:00

  • PCV140 The Impact of National Mass Screening Program on Health Service Utilizations and Medical Expenses- In the Case of Hypertension Complications

    Nov 1, 2011, 00:00

  • PHP99 Reimbursing Telemonitoring in Europe- Are Payers Ready?

    Nov 1, 2011, 00:00

  • PND11 Budget Impact Analysis of First-Line Treatment for Relapsing – Remitting Multiple Sclerosis in Spain

    Nov 1, 2011, 00:00

  • PCN46 Cost of Metastatic Prostate Cancer Treatment in the 12 Months Following Diagnosis per Patient in Russian Federation

    Nov 1, 2011, 00:00

  • PRM67 What EPRO Modality is Appropriate for Your Study?

    Nov 1, 2011, 00:00

  • PGI4 Cost-Effectiveness of Esomeprazole Versus Pantoprazole in Acute and Maintenance Treatments of Reflux Esophagitis in Turkey

    Nov 1, 2011, 00:00

  • PCN66 A Cost and Outcomes Analysis of Bevacizumab plus Folfiri Versus Cetuximab Plus Folfiri for the Treatment of First-Line Metastatic Colorrectal Cancer Patients from the Brazilian Private Payer Perspective

    Nov 1, 2011, 00:00

  • QA3 Costo-Efectividad De Dabigatran Versus Warfarina En El Manejo De La Fibrilacion Auricular En Colombia

    Nov 1, 2011, 00:00

  • PIN111 Dynamic Modeling of Cost-Effectiveness of 13-Valent Pneumococcal Conjugate Vaccination Against Streptococcus Pneumoniae in Taiwan

    Nov 1, 2011, 00:00

  • PHP165 A New Anti-Rebate Legislation in South Korea- Will It Work This Time?

    Nov 1, 2011, 00:00

  • PCN139 Human Papilloma Virus and Cervical Cancer - Knowledge and Interest of Man and Woman

    Nov 1, 2011, 00:00

  • PCN1 Burden of Hospitalization in Patients with Advanced Lung Cancer in France and Germany

    Nov 1, 2011, 00:00

  • PCN42 Treatment Costs of Bone Metastases in Patients with Lung Cancer- Results From A French Prospective, Observational, Multicenter Study (GFPC 0601)

    Nov 1, 2011, 00:00

  • PHP122 A Comparison of HTA Recommendations Issued by Agency for Health Technology Assessment in Poland (AHTAPol) and National Institute for Health and Clinical Excellence (NICE) in the UK – Consideration of Social Implications in HTA

    Nov 1, 2011, 00:00

  • PHP136 Radiology Diagnostics and Interventional Radiology Services Utilization Patterns and Economic Consequences Analysis in a Large Tertiary Care University Hospital – Three Year Trends

    Nov 1, 2011, 00:00

  • PMD29 A1CNow® as Ambulatory Monitoring of Glycated Hemoglobin in Diabetic Type 2 (DM2) Patients- Brazilian Economic Modeling

    Nov 1, 2011, 00:00

  • PHP18 Impacto De La Participacion Del Farmaceutico Como Parte Del Equipo De Salud En El Primer Nivel De atencion sobre Los Costos

    Nov 1, 2011, 00:00

  • PCN168 Cost-Effectiveness Analysis of Different Cervical Cancer Prevention Approaches in the United States

    Nov 1, 2011, 00:00

  • PRS63 Faciliators and Barriers Associated with the Use of Pharmacological – Behavioral Combination Therapy to Smoking Cessation

    Nov 1, 2011, 00:00

  • PCN140 Rural - Urban Differences in Fatalistic Beliefs About Cancer Prevention

    Nov 1, 2011, 00:00

  • PSS8 Advanced Cutaneous Melanoma in the UK- A Systematic Review

    Nov 1, 2011, 00:00

  • PMD16 The Economic and Efficiency Gains associated with the Use of A Standardised, Automated BCR-ABL Monitoring Test (SBAT)- Results from A Budget Impact analysis for the USA

    Nov 1, 2011, 00:00

  • PCV92 Cost Utility of Ranolazine in the Symptomatic Treatment of Patients with Chronic Angina Pectoris in Spain

    Nov 1, 2011, 00:00

  • PIH68 Studying Heterogeneity in Treatment Response in Women with Idiopathic Menorrhagia Treated with Levonorgestrel-Releasing Intrauterine System (LNG-IUS)- Application of Innovative Methods to Identify Differential Response

    Nov 1, 2011, 00:00

  • PHP48 Croatian Pharmaceutical Expenditure Before and After Healthcare Reform – Comparison to EU Countries

    Nov 1, 2011, 00:00

  • PMH1 Adjunctive Pharmacotherapy Among Initiators of SSRI Treatment for Major Depressive Disorder- A Cohort Study Using a UK Primary Care Database

    Nov 1, 2011, 00:00

  • MO2 Extrapolation in Oncology Modelling- Novel Methods for Novel Compounds

    Nov 1, 2011, 00:00

  • PMS43 Cost-Minimization Analysis of Collagenase Clostridium Histolyticum Compared with Fasciectomy in Patients with Dupuytren'S Contracture in Portugal

    Nov 1, 2011, 00:00

  • PCN122 Disclosing Traditional CM) Use to the Health Care Providers- A Qualitative Study Among Cancer Patients at a Local Hospital in Malaysia

    Nov 1, 2011, 00:00

  • PHP167 Tell Me Who Your Friends are- “Peers” in Comparing Health Care Systems

    Nov 1, 2011, 00:00

  • PRM7 Using Probabalistic Sensitivity Analysis in Budget Impact Models to Reduce Uncertainty and Improve Decision-Making

    Nov 1, 2011, 00:00

  • PHP27 Diffusion of Innovations in Health Care- Does the Dual Market Phenomenon Exist?

    Nov 1, 2011, 00:00

  • PCN10 Analisis De Minimizacion De Costos Entre El Uso De Iopromide Mediante Un Sistema De Aplicacion En Cascada (SIAC) Frente Al Uso De Otros Medios De Contraste Convencionales En Radiologia Invasiva En Colombia

    Nov 1, 2011, 00:00

  • PCN45 Projection of the Patients' Population Treated for Chronic Myeloid Leukemia in Chronic Phase in Fran An Epidemiological Model at the Horizon 2015

    Nov 1, 2011, 00:00

  • PSS33 Estimation of Meaningful Change on the Skindex-29 and Dermatology Life Quality Index in Patients With Chronic Hand Eczema

    Nov 1, 2011, 00:00

  • PCV128 A Real World Evaluation to Describe the Characteristics, Outcomes and Resource Use Associated with Patients Being Managed by a Secondary Care Based Anticoagulation Service

    Nov 1, 2011, 00:00

  • PCN32 Cost Savings With Bevacizumab Compared to Sunitinib in the Treatment of MRCC

    Nov 1, 2011, 00:00

  • PCN195 Bayesian Calibration of A Cervical Cancer Model Using Markov Chain Monte Carlo

    Nov 1, 2011, 00:00

  • PMH9 Prescribing Patterns and Cost of Drugs for Alzheimer's Disease

    Nov 1, 2011, 00:00

  • PHP150 Pharmaceutical Pricing Under Uncertainty- Risk-Sharing Contracts

    Nov 1, 2011, 00:00

  • PMS7 Direct Treatment-Cost of Patients with Rheumatoid Arthritis in Medellin, Colombia

    Nov 1, 2011, 00:00

  • PHP7 Orphan Drugs for Rare Diseases in the European Union- Bridging the Gap between Drug Development and Unmet Medical Needs?

    Nov 1, 2011, 00:00

  • PMH60 Factors Associated with Health-Related Quality of Life in Alcohol Dependent Patients

    Nov 1, 2011, 00:00

  • PND55 The Predictors of Health-Related Quality of Life in Pediatric Epilepsy- A Systematic Review

    Nov 1, 2011, 00:00

  • PCN29 Budgetary Impact of Adoption of Erlotinib for Lung Cancer in the Private Health Insurance Market in Brazil- A Real World Data Analysis

    Nov 1, 2011, 00:00

  • PMS37 The Cost Effectiveness of Glucosamine Sulphate Powder (Glusartel) for the Treatment of Osteoarthritis of the Knee

    Nov 1, 2011, 00:00

  • PHP12 The Ratio of Public Reimbursement and Patients' Co-Payment in the Financing of Spa Services in Hungary

    Nov 1, 2011, 00:00

  • PCN59 Economics of Primary Prophylactic G-CSF Use in Preventing Neutropenia in Elderly Breast Cancer Patients Receiving Chemotherapy- Are Short-Term Increase in Costs Necessarily Bad?

    Nov 1, 2011, 00:00

  • PRM29 Translation and Validation Study of Morisky Medication Adherence Scale (MMAS)- The Urdu Version

    Nov 1, 2011, 00:00

  • PCV2 Estimated Cost of Acute Coronary Syndrome for 2011- Case of Mexico

    Nov 1, 2011, 00:00

  • PMH15 Mortality in relation to Disease Severity in Subjects with Dementia

    Nov 1, 2011, 00:00

  • PIN47 Cost-Effectiveness of Telbivudine in First Line Treatment of HBEAG-Negative Patients with Chronic Hepatitis B (CHB) in the Turkish Healthcare Setting

    Nov 1, 2011, 00:00

  • PCV107 Correlation of Physician-Rated Adherence with Therapeutical Outcomes in Antihypertensive Treatment- Pooled Analysis Findings from Six Valsartan Studies Including 15,583 Available Patients

    Nov 1, 2011, 00:00

  • PHP139 Evolving PR Complexities are Affecting Launch Sequencing and Time to Market in 18 Developed and Emerging Markets

    Nov 1, 2011, 00:00

  • PCN144 Health-Related Quality of Life in Prostate Cancer – One Year Follow-up and Comparison with General Population Norms

    Nov 1, 2011, 00:00

  • PMD48 An Economic Evaluation of the Heartware Ventricular assist Device in the NHS

    Nov 1, 2011, 00:00

  • PDB34 Medical Treatment Costs Attributable to Obesity in Diabetic Patients in the United States

    Nov 1, 2011, 00:00

  • PHP163 Pharmaceutical Innovation- Definition, and Mechanisms for Reward

    Nov 1, 2011, 00:00

  • PIN19 Pharmacoeconomic Analysis of Pegylated Interferon Alfa Use in Chronic Hepatitis C

    Nov 1, 2011, 00:00

  • PCV120 Quality of Life in Chronic Symptomatic Heart Failure Patients in Spain, insight from the Inoescaro Study

    Nov 1, 2011, 00:00

  • PSU8 Risks and Benefits of Acrysof® Cachet™ Implantation in High Myopia (≥-6 DIOPTRE)- A Systematic Literature Review

    Nov 1, 2011, 00:00

  • PDB36 Estimating the Average Annual Cost of Treatment with Insulin for Patients with Type 2 Diabetes Mellitus

    Nov 1, 2011, 00:00

  • PCN62 Costs and Consequences of HPV Vaccination in Thailand- Results of a Prevalence Based Model

    Nov 1, 2011, 00:00

  • PIH64 Female Urinary Incontinence in Germany– Cost Explosion Tomorrow?

    Nov 1, 2011, 00:00

  • PSY6 The Health Improvement Network (Thin) 2008-2009 Estimates of Psoriasis Incidence and Prevalence in Uk Primary Care

    Nov 1, 2011, 00:00

  • PR1 Responsiveness of the Copd Assessment Test (CAT) Questionnaire During Exacerbations of COPD

    Nov 1, 2011, 00:00

  • PDB69 Prescription Pattern Study of Type 2 Diabetes Mellitus in Iran

    Nov 1, 2011, 00:00

  • PIH51 What Do Patients with Rare Diseases Experience in the Medical Encounter? Exploring Patient-Physician-Interaction Patterns, Its Antecedents and Its Consequences

    Nov 1, 2011, 00:00

  • PCN12 Dasatinib or Imatinib in Newly Diagnosed Chronic Myeloid Leukemia Patientes in the Chronic Phase- Five-Years Follow-up Simulated Cohort

    Nov 1, 2011, 00:00

  • PND27 Economic Analysis of Cost Per Episode of Care for Arm Spasticity and Cervical Dystonia- Comparison of Two Botulinum Toxin A Preparations in 20 Countries

    Nov 1, 2011, 00:00

  • PSY2 Coexistence of Immuno-Mediated Inflammatory Diseases- an Analysis of the Quebec Administrative Health Databases

    Nov 1, 2011, 00:00

  • PMH61 A Descriptive Analysis of Atomoxetine Utilization in Attention Deficit/Hyperactivity Disorder (ADHD) the United Kingdom and Italy

    Nov 1, 2011, 00:00

  • PMD67 The Cost-Effectiveness of Transcatheter Aortic Valve Implantation in Elderly Patients with Severe Aortic Stenosis Who are Contraindicated for Conventional Surgical Aortic Valve replacement in the United Kingdom

    Nov 1, 2011, 00:00

  • PUK4 Comparing Projected Outcomes of Renal Transplant Recipients Based on Trial Endpoint of Renal Function and Receiving Different Immunosuppressive Regimens in the United States

    Nov 1, 2011, 00:00

  • PHP52 Inequalities in the Utilization of Home Hospice Services in Hungary

    Nov 1, 2011, 00:00

  • PRS23 High Cost Cystic Fibrosis Patients as Identified in a Us Claims Database- A Closer Look at the Tail

    Nov 1, 2011, 00:00

  • PCN132 A Development of Quality Indicators for Evaluating Home Palliative Care and Their Relation with Bereaved Family Satisfaction

    Nov 1, 2011, 00:00

  • PCN116 Cost-Effectiveness of Denosumab Versus Zoledronic Acid (ZA) for the Prevention of Skeletal-related Events (SRE) in Patients with Bone Metastases from Solid Tumors in the Netherlands

    Nov 1, 2011, 00:00

  • PGI19 Stress Ulcer Bleeding Prophylaxis with Proton Pump Inhibitors, H2 Receptor Antagonists or Sucralfate- A Cost-Effectiveness Analysis

    Nov 1, 2011, 00:00

  • PCV49 Evaluating the Management of the Rehabilitation Unit in A Tertiary Referral Hospital in Spain- A Cost-Analysis Study

    Nov 1, 2011, 00:00

  • PMH44 Improving Health-Related Quality of Life for Patients with Refractory Post-Traumatic Stress Disorder- Use of Local Anesthetics Show Promise in a Clinical Case Series

    Nov 1, 2011, 00:00

  • PMS21 Differences in Cost-of-Illness and Quality of Life Between Rheumatoid Arthritis and Ankylosing Spondylitis in South Korea

    Nov 1, 2011, 00:00

  • PMS72 Assessment of Prior Use of Prescribed Pain Medications Among Elderly Patients Who Initiated Duloxetine

    Nov 1, 2011, 00:00

  • PCN106 Capecitabine Plus Oxaliplatin (CAPOX) Versus Fluorouracil/Leucovorin plus Oxaliplatin (FOLFOX) in Stage III Colon Cancer- A Cost-Minimization Analysis Based on Real World Costs in the Netherlands

    Nov 1, 2011, 00:00

  • PHP144 Multi-Stakeholder Survey of Comparative Effectiveness Research Perceptions

    Nov 1, 2011, 00:00

  • PMH3 Olanzapine Long-Acting Injection for Schizophrenia- An Evaluation of Patient Functioning During 24 Weeks of Maintenance Therapy

    Nov 1, 2011, 00:00

  • PHP6 Regional Variability in the Generic Antidepressant Market in Spain

    Nov 1, 2011, 00:00

  • PHP5 Analysis of Linked Medical Claims Data for Preinvestigation in Modeling Studies

    Nov 1, 2011, 00:00

  • PIN3 Pursuing Financial Sustainability To Fulfill The Millenium Development Goal Six In A Fragmented SYSTEM. The Experience Of The Universal Access To Antiretroviral Drugs In MÉxico 2007-2009

    Nov 1, 2011, 00:00

  • PSU9 Incidence of Major Surgeries in Patients with Metastatic Colorectal Cancer

    Nov 1, 2011, 00:00

  • PCN101 A Cost-Effectiveness Analysis for Second-Line Treatment of Relapsed/Refractory (RR) Multiple Myeloma (MM) in the United Kingdom

    Nov 1, 2011, 00:00

  • PDB10 Achieving Target Goals in Patients with T2DM Treated with Exenatide Once Weekly or Insulin Glargine- A Retrospective Analysis of the Number-Needed-To-Treat

    Nov 1, 2011, 00:00

  • PHP59 Estimation of Increases in Direct Medical Expenditures Associated with Medication Nonadherence and Potential Savings from Increased Adherence

    Nov 1, 2011, 00:00

  • PDB50 Reduction in Comorbidities and Cost Savings Associated with Biochemical Control in Patients with Cushing's Disease- A Literature-Based Analysis

    Nov 1, 2011, 00:00

  • PCV127 Time to Initiation of Oral Antihyperglycaemic and Statin Therapy in Patients with Newly Diagnosed Type 2 Diabetes Mellitus

    Nov 1, 2011, 00:00

  • PRS39 Cost-Effectiveness of Roflumilast in Combination with Bronchodilator Therapies in Patients with Severe and Very Severe COPD in Switzerland

    Nov 1, 2011, 00:00

  • PIN57 Cost-Effectiveness of the New Guidelines for the Prevention of Mother to Child Transmission of HIV in Uganda

    Nov 1, 2011, 00:00

  • PMS5 The Effect of one-Time Physical Therapy on Biochemical Markers of Bone Metabolism

    Nov 1, 2011, 00:00

  • PCN27 Budget Impact Analysis for Chronic Mieloid Leukemia Therapy in Bulgaria

    Nov 1, 2011, 00:00

  • PDB14 Assessment of the Clinical and Economic Benefits of Adequate Insulin Initiation and Intensification in People with Type 2 Diabetes Mellitus

    Nov 1, 2011, 00:00

  • PMS49 Cost-Effectiveness of Rituximab in the Treatment of RA Patients in the Netherlands

    Nov 1, 2011, 00:00

  • PSU24 Comparison of the Responsiveness of the SF-36 and the Raw and Rasch-Based Scores of the Oxford Knee Score in Patients Undergoing Total Knee Replacement

    Nov 1, 2011, 00:00

  • PCV30 Heart Failure (Re)Admissions in the Netherlands- Rates, Length of Stay and Costs

    Nov 1, 2011, 00:00

  • PHP57 Centralized Drug Assessment in Catalonia- Where We Have Gone so Far?

    Nov 1, 2011, 00:00

  • PCN107 Potential Benefits of Introducing A Companion Diagnostic in Advanced Non-Small Cell Lung Cancer

    Nov 1, 2011, 00:00

  • PHP50 The Valuation of End-of-Life Health Gains

    Nov 1, 2011, 00:00

  • PHP142 Landmark CER Study Methods Review

    Nov 1, 2011, 00:00

  • PDB30 Assessment of the Impact of the New Antidiabetic Treatment with Vildagliptin to Change the Total Costs on Diabetes Type 2

    Nov 1, 2011, 00:00

  • PMS46 Cost-Utility Analysis of Certolizumab Pegol versus Alternative Tumor Necrosis Factor-Inhibitors, for the Treatment of Moderate-to-Severe Rheumatoid Arthritis in Spain

    Nov 1, 2011, 00:00

  • PCV91 Cost-Effectiveness of Endovascular Treatment Versus Open Surgery in Patients with Steno-Occlusive Disease of the Femoral Artery

    Nov 1, 2011, 00:00

  • PMD5 Diagnostic Accuracy of Clinical Characteristics following Minor Head injury- A Systematic review and Meta-analysis

    Nov 1, 2011, 00:00

  • MO4 Outcomes Beyond Health

    Nov 1, 2011, 00:00

  • PIN69 Methodological Challenges for Economic Evaluations of Vaccination Programs- The Case of Pertussis Booster Vaccination

    Nov 1, 2011, 00:00

  • PCN36 The Economic Impact of Treating Early Lung Cancer- A Systematic Review

    Nov 1, 2011, 00:00

  • PCN119 Lack of Data for Indirect Costs Associated With Treatment of Early Breast Cancer

    Nov 1, 2011, 00:00

  • PCN53 Economic Burden of HPV-Related Head Neck and Anal Cancers in Germany

    Nov 1, 2011, 00:00

  • PND3 Estimación Del proceso De procuración De órganos De Pacientes Con Muerte Cerebral En México 2009

    Nov 1, 2011, 00:00

  • PCN166 Public Accountability and Social Judgment in the Reimbursement Decision for Oncology Medications in Korea

    Nov 1, 2011, 00:00

  • PSY53 Changes in Concomitant therapy for Weight-related Illness Following Initiation of Weight Loss Pharmacotherapy

    Nov 1, 2011, 00:00

  • PRM33 Systematic Review of Health State Utilities in Spain

    Nov 1, 2011, 00:00

  • PRS12 A Budget Impact Analysis to Estimate the Economic Impact Of Beclomethasone/Formoterol for the Treatment of Moderate to Severe Persistent Asthma in Six Spanish Regions

    Nov 1, 2011, 00:00

  • PMD15 Societal Costs of Routine Follow-up Services for Cardiac Implantable Electrical Devices in Germany and the United Kingdom - and the Impact of remote Monitoring

    Nov 1, 2011, 00:00

  • PRM16 Covariance Structures for Modeling Longitudinal Data

    Nov 1, 2011, 00:00

  • PHP97 Use of Paediatric “Observation Status” and Effect on in-Patient Admission Rate in Accident and Emergency (AE) Departments

    Nov 1, 2011, 00:00

  • PUK9 Comparative Cost Analysis of Treatment for Renal Anemia with Methoxy Polyethylene-Glycol Erythropoietin Beta (MIRCERA®) Versus Erythropoietin Beta (NEORECORMON®)

    Nov 1, 2011, 00:00

  • PCN149 Health State Utility Values in Breast Cancer- A Review and Meta-Analysis

    Nov 1, 2011, 00:00

  • PHP152 The Administrative Burden of Patient Access Schemes in the Changing UK Health Care System- A Follow Up Study

    Nov 1, 2011, 00:00

  • PHP115 Preliminary Analysis of the Unwritten Decision Rules Behind the French Transparency Commission'S Assessment of Drugs

    Nov 1, 2011, 00:00

  • PMD21 The Clinical and Economic Benefits of Spinal Cord Stimulation in the Treatment of Failed Back Surgery Syndrome (Precise Study)

    Nov 1, 2011, 00:00

  • PIH59 Are Older Mothers More prone to Having Children with Disabilities? Lifetime Disability Outcomes Versus Multiple Birth Reductions Arising from In-Vitro Fertilization (IVF) Treatments in Canada

    Nov 1, 2011, 00:00

  • PMS4 Efficacy and Effectiveness of Collagenase Clostridium Histolyticum for Dupuytren'S Contracture

    Nov 1, 2011, 00:00

  • VI1 Determining the Impact of Modeling Additional Sources of Uncertainty in Value of Information Analysis

    Nov 1, 2011, 00:00

  • PCN114 Cost Effectiveness of Adjuvant Cyclophosphamide in the Treatment of Breast Cancer in Spain

    Nov 1, 2011, 00:00

  • PCV11 Treatment and 12-Month Outcomes of Acute Coronary Syndromes Patients Aged 75 and ≥ 75 Years Undergoing Percutaneous Coronary Intervention- 14-Country Data on 4545 Patients from the Prospective Antiplatelet Treatment Outcomes Registry ...

    Nov 1, 2011, 00:00

  • PSU16 Minimally Invasive Surgery in Total Hip Arthroplasty- A Cost-Effectiveness Analysis

    Nov 1, 2011, 00:00

  • PRS29 Evaluation of Stable COPD Medication Costs in Ukraine Based on GPS' Prescriptions Habits Survey Results

    Nov 1, 2011, 00:00

  • PDB17 Off-Label and Non-Licensed Endocrinology Medicine Use in Turkey- A Retrospective Analysis of Computer Records in the Turkish Ministry of Health

    Nov 1, 2011, 00:00

  • PCN49 Incidence Rate and Burden of Illness Associated with Human Papillomavirus Related Genital Cancers in Spanish Women

    Nov 1, 2011, 00:00

  • PRM18 Sensitivity Analysis in Multi-Criteria Decision (MCDA) Models for Benefit-Risk Assessment

    Nov 1, 2011, 00:00

  • PHP151 Evidence on the Impact of Managed Entries on Payers, Patients, Manufacturers, and Health Care Workers

    Nov 1, 2011, 00:00

  • PHP83 The Economic Burden of Disease Related Malnutrition in Europe

    Nov 1, 2011, 00:00

  • PSS4 Development of a Questionnaire Assessing the Burden of Ichthyosis in Infants

    Nov 1, 2011, 00:00

  • PND32 Cost-Utility Analysis of Ropinirole in Parkinson'S Disease (PD) Treatment

    Nov 1, 2011, 00:00

  • VI3 Sequential Treatment of Follicular Non-Hodgkin Lymphoma- Cost-Effectiveness and Value of information

    Nov 1, 2011, 00:00

  • PHP169 The Values of General Practitioners/Family Physicians Should Be Fostered into Other Clinicians- A Research Study

    Nov 1, 2011, 00:00

  • PIN26 Economic and Health Related Quality of Life (HRQL) Comparison of Lopinavir/Ritonavir (LPV/R) and Atazanavir Plus Ritonavir (ATV+RTV)-Based Regimens for Antiretroviral (ARV) Experienced Brazilian Patients in 2011

    Nov 1, 2011, 00:00

  • VI4 the Value of information of A Multicentre Randomised Controlled Trial of intravenous Immunoglobulin for Sepsis (Severe Sepsis and Septic Shock)

    Nov 1, 2011, 00:00

  • PGI28 Disease-Specific Health-related Quality of Life in Patients with Quiescent Ulcerative Colitis- Effects of one Year Maintenance Treatment with MMX Mesalamine

    Nov 1, 2011, 00:00

  • PMD36 Cost-Effectiveness of the Ex-Press Glaucoma Filtration Device in the Netherlands

    Nov 1, 2011, 00:00

  • PRS69 Socioeconomic Determinants of Smoking Status in Greece

    Nov 1, 2011, 00:00

  • PDB8 A Network Meta Analysis to Compare Glycaemic Control in Patients with Type 2 Diabetes Treated with Exenatide Once Weekly or Liraglutide

    Nov 1, 2011, 00:00

  • PCV115 The Sensitivity of Pro's in Evaluating Adverse Events in People Receiving “Statin” Therapy

    Nov 1, 2011, 00:00

  • PMD40 Cost Effectiveness of Fractional Flow reserve Measurement in Multivessel Coronary Artery Disease in Belgium and France

    Nov 1, 2011, 00:00

  • PMH51 Measuring Relapse After Substance Abuse Treatment- A Proportional Hazard Approach

    Nov 1, 2011, 00:00

  • PIH23 Cost-Effectiveness of Guanfacine Extended Release as an Adjunctive Therapy to a Psychostimulant Compared to Psychostimulant Monotherapy for the Treatment of Attention Deficit/Hyperactivity Disorder in Children and Adolescents

    Nov 1, 2011, 00:00

  • AD2 Cost-Consequence Analysis of Switching From An Oral Antipsychotic To Long Acting Injectable Risperidone Among Patients With Schizophrenia

    Nov 1, 2011, 00:00

  • PND63 Drug Prescription in and Hospitalization of Refractory Focal Epilepsy Patients in the German Neurotransdata (NTD) Neurologists' Network – is There An Unmet Need?

    Nov 1, 2011, 00:00

  • RM4 Factores Predictores De Obstrucciones Coronarias Significativas En Pacientes Adultos Con CineangiocoronariografÍas Realizadas En Uruguay, Financiadas Por El Fondo Nacional De Recursos

    Nov 1, 2011, 00:00

  • PSU21 Speech Problem and Health-Related Quality of Life in Head and Neck Cancer Survivors After Five Years of Treatments

    Nov 1, 2011, 00:00

  • PMD49 The Potential Role of Magnetic Resonance Imaging (MRI) in Axillary Node Assessment of Early Breast Cancer- An Economic Evaluation

    Nov 1, 2011, 00:00

  • PMD25 Cost-Effectiveness of Transcatheter Aortic Valve Implantation (TAVI) in High-Risk or Inoperable Patients with Symptomatic Aortic Valve Stenosis in Spain

    Nov 1, 2011, 00:00

  • PMH38 Buprenorphine/Naloxone Versus Buprenorphine and Methadone in Heroin Addiction Detoxification- An Italian Cost-Utility Analysis

    Nov 1, 2011, 00:00

  • PSY1 Tolerability of Oral Long-Acting Opioids in the Treatment of Chronic Pain- a Systematic Literature Review and Meta-Analysis

    Nov 1, 2011, 00:00

  • PHP101 Biosimilars are Not Generics from Payer Perspective

    Nov 1, 2011, 00:00

  • PCN126 Which Factors Can Affect Utilities?

    Nov 1, 2011, 00:00

  • NI1 The UK Nice Single Technology Appraisal Process- A Qualitative Study Based on Manufacturers' Submissions

    Nov 1, 2011, 00:00

  • PDB51 A Comparison of Insulin Adherence in Patients with Type 2 Diabetes Initiating Therapy with Insulin Detemir Flexpen® or NPH Insulin in a Vial

    Nov 1, 2011, 00:00

  • PIN39 Cost Analysis of Antibiotic Therapy of Acute Peritonitis in Ukraine

    Nov 1, 2011, 00:00

  • PHP3 A Review of Breast Cancer (BC) Care and Outcomes in Latin America Caribbean (LAC)

    Nov 1, 2011, 00:00

  • PCV54 First-Year Direct Medical Cost of Newly Diagnosed Stable Angina in Hong Kong

    Nov 1, 2011, 00:00

  • RS3 Evidence, Process or Context? Examining The Factors That Drive Coverage Decisions Of Pharmaceuticals By Health Technology Assessment Bodies In Europe

    Nov 1, 2011, 00:00

  • PMH47 Validity of the Q10 Questionnaire for Diagnosis of Wearing-off Phenomena in Parkinson's Disease- A Q10 Study

    Nov 1, 2011, 00:00

  • PHP166 On-Going Market Access Advice A Possible solution to Help Ensure Long-Term Success in Post-Marketing Clinical Studies- Cross Functional Teams or External Consultation?

    Nov 1, 2011, 00:00

  • PIN73 Modeling the Long Term Clinical Outcomes and Health Care Cost Impact of Initiating Treatment with Atazanavir/R Compared with Darunavir/R, Lopinavir/R and Efavirenz for HIV-1 Infected Treatment-NaÏve Patients- Country Results for Italy ...

    Nov 1, 2011, 00:00

  • MO1 Methods for Extrapolating Survival Data Used in NICE Technology Appraisals- Inconsistencies and Limitations

    Nov 1, 2011, 00:00

  • PMD57 Data Visualization for Business Intelligen Assessing an Online Tool Used for Benchmarking Hospital Procedure Costs to Reimbursment in Cardiac Catheterization and Electophysiology Procedures

    Nov 1, 2011, 00:00

  • PCN158 The Influence of Health Care Policies and Health Care System Distrust on Willingness to Undergo Genetic Testing

    Nov 1, 2011, 00:00

  • PCN19 The Broader Burden of HPV-related Disease in England- A Preliminary Analysis

    Nov 1, 2011, 00:00

  • PHP2 Describing Trends and Determinants of Non-Opioid Analgesic (NOA) Prescribing in Chronic Non-Cancer Pain Patients in the United States Outpatient Settings

    Nov 1, 2011, 00:00

  • PHP132 Use of a Disease Specific Quality of Life Tool in a Quality Assurance Scheme for Day Case Hernia Surgery

    Nov 1, 2011, 00:00

  • PHP109 Tendering of Biosimilars in the UK – Does Launch Price Actually Matter?

    Nov 1, 2011, 00:00

  • PMD28 Cost-Effectiveness Analysis of Three Leprosy Case Detection Methods in Northern Nigeria

    Nov 1, 2011, 00:00

  • PHP51 Patient-Centered Care- Challenges for Brazil, Lessons for United States

    Nov 1, 2011, 00:00

  • PCV18 Relative Efficacy of Bivalirudin vs. Heparin Alone in STEMI Patients Treated with Primary PCI – an Indirect Treatment Comparison

    Nov 1, 2011, 00:00

  • PMH35 A Cost-Effectiveness Analysis of Paliperidone Palmitate Versus Olanzapine Pamoate in the Treatment of Schizophrenia in Norway

    Nov 1, 2011, 00:00

  • PHP60 Drug-related Morbidity – Modeling the Cost-of-Illness in Sweden Using Pharmacists' Opinion

    Nov 1, 2011, 00:00

  • PIN43 The Total Cost of HIV Patients Treated with ARV Therapy- Real World Evidence from Three Italian Administrative Databases

    Nov 1, 2011, 00:00

  • PDB32 Cost of Diabetes and its Complications in Poland- Preliminary Results

    Nov 1, 2011, 00:00

  • PCN4 Effect of Antiemetic Prophylaxis Against Chemotherapy-Induced Nausea and Vomiting with 5-HT3 Receptor Antagonists in Patients with Lymphoma

    Nov 1, 2011, 00:00

  • PCN52 Economic Impact of Healthcare Resource Utilisation Patterns Among Patients Diagnosed with Advanced Melanoma in the UK, Italy, and Fran Results From a Retrospective, Longitudinal Survey (Melody Study)

    Nov 1, 2011, 00:00

  • PIH2 Caress- The Canadian Registry of Synagis (2005-2010)

    Nov 1, 2011, 00:00

  • PSY12 Laparoscopy Versus Open Roux-en-y Gastric Bypass For Morbid Obesity- Cost-Utility Analysis

    Nov 1, 2011, 00:00

  • PCV85 Cost-Effectiveness of Increasing Statin Adherence for Secondary Prevention in Community Pharmacies

    Nov 1, 2011, 00:00

  • Instructions for Authors

    Nov 1, 2011, 00:00

  • PCV7 Cost-Effectiveness of Prasugrel Versus Clopidogrel in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention in the Public Health Care System in Mexico

    Nov 1, 2011, 00:00

  • PMS73 Epidemiology, Therapy Patterns and Functional Status of Patients with Juvenile Idiopatic Arthritis (JIA) in Russia

    Nov 1, 2011, 00:00

  • PDB4 Characterization of the Risk for Urinary Tract Infections in US Patients with Type 2 Diabetes Mellitus

    Nov 1, 2011, 00:00

  • PMD64 The Effect of Supplementary Fees on the Diffusion of Medical Devices in the German System of Diagnosis related Groups (G-Drg)- The Case of Drug-Eluting Stents in Patients with Acute Myocardial Infarction

    Nov 1, 2011, 00:00

  • PCV13 Comparing the Effectiveness of Rosuvastatin and Atorvastatin in Preventing Cardiovascular Events for Populations Stratified by Baseline Cardiovascular Risk- Estimates Using the Archimedes Model

    Nov 1, 2011, 00:00

  • PRM32 Feasibility and Validity of the TiC-P

    Nov 1, 2011, 00:00

  • PMD76 Are Health Technology Assessments of Medical Devices Catching up with Pharmaceuticals?

    Nov 1, 2011, 00:00

  • PCN95 The Cost-Effectiveness of Aprepitant for the Prevention of Nausea and Vomiting Induced by Moderately Emetogenic Chemotherapy in Breast Cancer Patients Compared to Current Clinical Practice in Scotland

    Nov 1, 2011, 00:00

  • PMH73 Increasing Use of Medication for Treatment of Attention-Deficcit/Hyperactivity Disorder (ADHD) in Germany between 2003 and 2009

    Nov 1, 2011, 00:00

  • PIN49 Cost-Effeectiveness of Earlier Initiation of First Line Combination Antiretroviral Therapy in an Urban Outpatient HIV Clinic in Uganda

    Nov 1, 2011, 00:00

  • PSS38 3-D Study - Description of the Care of the Dental Pain

    Nov 1, 2011, 00:00

  • PRM1 attaching Value to Non-Efficacy Metrics- A Pricing Study

    Nov 1, 2011, 00:00

  • PMD45 Optar Study- Transcatheter Aortic Valve Implantation (TAVI) versus Optimal Medical Treatment (OMT) in prohibitive Surgical Risk Patients with Severe Aortic Stenosis (AS) – An Exploratory Cost-Effectiveness Analysis

    Nov 1, 2011, 00:00

  • PIH18 Rotavirus Gastroenteritis in Vulnerable Children- A UK Case Control Study

    Nov 1, 2011, 00:00

  • PRS14 Estimating the Budget Impact of Introducing Indacaterol in the Treatment Of Chronic Obstructive Pulmonary Disease (COPD) from the Public Payer Perspective in SÃo Paulo

    Nov 1, 2011, 00:00

  • ISPOR 14th Annual European Congress Research Abstracts Author Index

    Nov 1, 2011, 00:00

  • PHP87 Patient-Centered Health Care Delivery Systems- A Discrete Choice Experiment

    Nov 1, 2011, 00:00

  • PSY29 Economic Evaluation of Capsaicin Patch 8% in the Treatment of Neuropathic Pain in Austria

    Nov 1, 2011, 00:00

  • PCN142 Methodological Limitations of Patient-Reported Outcome Measures (PROMs) in oncology- A Meta-Review

    Nov 1, 2011, 00:00

  • PCV58 the Impact of Comorbid Mental Illness on Costs of Health Care for Inpatients with Heart Failure

    Nov 1, 2011, 00:00

  • PHP72 Evidence-Based Priority Setting for the National Health Development Plan of Thailand

    Nov 1, 2011, 00:00

  • PMD53 Pulmonary Vein isolation for the Treatment of Paroxysmal AF- Time reduction and productivity Gain with “anatomically-Designed” Cathethers Compared to “Point by Point” Catheters

    Nov 1, 2011, 00:00

  • PIN44 Cost-Effectiveness of Quadrivalent HPV Vaccination in Germany Using A Dynamic Transmission Model

    Nov 1, 2011, 00:00

  • PDB21 Natural History of Beta Cell Rate of Decline and Its Effect on Development of Secondary Complications in Type 1 Diabetes

    Nov 1, 2011, 00:00

  • PDB26 Projected Long-Term Clinical and Economic Outcomes of Exenatide Once Weekly Versus Sitagliptin for the Treatment of Type 2 Diabetes in the UK

    Nov 1, 2011, 00:00

  • PHP156 Novel Drug Reimbursement Models- Lessons and Implications from Cancer Drug Access Schemes

    Nov 1, 2011, 00:00

  • PHP112 Inter-Individual Country Variability in Monoclonal Antibodies (MABS) Reimbursement and Coverage Following EMA Approval

    Nov 1, 2011, 00:00

  • PDB57 Polish Health Care System for Diabetic Patients- The Analysis of Current Health Care System and the Need of Community Pharmacy Implementation

    Nov 1, 2011, 00:00

  • PHP39 Gauging the Role of HTA in Reimbursement Decision-Making Across Five Markets in Latin America

    Nov 1, 2011, 00:00

  • PCV28 Control of Hypertension in Spain- A Systematic Review and Meta-Analysis of 76 Epidemiological Studies on 341,632 Participants

    Nov 1, 2011, 00:00

  • PCN34 Cost Analysis of Anemia Treatment with Erythropoiesis-Stimulating Agents (ESAs) in Cancer Patients Receiving Chemotherapy in Italy

    Nov 1, 2011, 00:00

  • PMD59 Complicated Parkinson'S Disease- Discrete Choice Analysis to Assess Patients' Preferences. A Pilot Study

    Nov 1, 2011, 00:00

  • PCN26 Long-Term Fiscal Implications of Mepact in the Treatment of High-Grade Non-Metastatic Osteosarcoma- A Budget Impact Model and A Lifetime Tax Perspective

    Nov 1, 2011, 00:00

  • PMH10 Exposure to Antipsychotic Medications During Four Year Periods Following Treatment Initiation among Children Under Six Years Old

    Nov 1, 2011, 00:00

  • PMH4 Economic Assessment Of Major Depressive Disorder Treatment Under Different Therapeutic Classes At Issste

    Nov 1, 2011, 00:00

  • PMH68 Differential Use of Extended and Instant Release Quetiapine- A Naturalistic Study of Finnish Inpatients with Schizophrenia Spectrum or Bipolar Disorders

    Nov 1, 2011, 00:00

  • PCN48 Costs of Tuberous Sclerosis Complex (TSC) Neurological and Developmental Manifestations in Brazil

    Nov 1, 2011, 00:00

  • RS1 Literature Review On Patient Access Schemes, Flexible Pricing Schemes And Risk Sharing Agreements For Medicines

    Nov 1, 2011, 00:00

  • PCV98 Estimating Willingness to Pay for Hypertension Outpatient Benefit Packages

    Nov 1, 2011, 00:00

  • PCV106 Predictors of Health Related Quality of Life in a Hypertensive Population

    Nov 1, 2011, 00:00

  • CN4 Evaluacion De Costos Del Tratamiento De Primera Linea Para Cancer Colorrectal Metastasico (Mcrc) Con Esquemas Basados En- Folfiri, Folfox O Xelox Mas Bevacizumab, En Cinco Instituciones Mexicanas

    Nov 1, 2011, 00:00

  • DA3 The Power of Assumptions

    Nov 1, 2011, 00:00

  • PMH39 Cost Effectiveness of A Collaboratieve Care Stepped intervention for Anxiety Disorders in the Primairy Care Setting

    Nov 1, 2011, 00:00

  • PSY34 Economic Evaluation of Ferinject in the Treatment of Anemia Patients in the Greek Hospital Setting- a Cost Minimization Analysis

    Nov 1, 2011, 00:00

  • PDB5 Micro- and Macrovascular Outcomes in Primary Care Patients with Type 2 Diabetes Treated with Insulin Glulisine or Human Regular Insulin- A Retrospective German Database Analysis

    Nov 1, 2011, 00:00

  • PIH55 Necessity of Admissions and Hospitalizations in Selected Teaching University Affiliated and Private Hospitals of Shiraz, Iran in 2007

    Nov 1, 2011, 00:00
  • «
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129 (current)
  • 130
  • »